Curative Biotechnology, Inc. (CUBT)
OTCMKTS: CUBT · Delayed Price · USD
0.0210
+0.0020 (10.53%)
Jul 3, 2024, 12:58 PM EDT - Market closed
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $13.21 million as of July 3, 2024. Its market cap has increased by 46.14% in one year.
Market Cap
13.21M
Enterprise Value
14.48M
1-Year Change
46.14%
Ranking
n/a
Category
Stock Price
$0.02
Market Cap Chart
Since July 5, 2019, Curative Biotechnology's market cap has increased from $3.23K to $13.21M, an increase of 409,050.65%. That is a compound annual growth rate of 428.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 17.16M | -10.80% |
| Dec 29, 2023 | 19.24M | 66.07% |
| Dec 30, 2022 | 11.59M | 6,448.69% |
| Dec 31, 2021 | 176.91K | -98.19% |
| Dec 31, 2020 | 9.75M | 1,242.22% |
| Dec 31, 2019 | 726.30K | 22,400.02% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 862.02B |
| Novo Nordisk | 628.28B |
| UnitedHealth Group | 458.57B |
| Johnson & Johnson | 351.45B |
| Merck & Co. | 323.49B |
| AbbVie | 293.06B |
| AstraZeneca | 238.71B |
| Novartis AG | 208.25B |